Pittsburgh, PA2 Active Studies

Familial Hypercholesterolemia Clinical Trials in Pittsburgh, PA

Find 2 actively recruiting familial hypercholesterolemia clinical trials in Pittsburgh, PA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
229
Enrolling

Recruiting Familial Hypercholesterolemia Studies in Pittsburgh

About Familial Hypercholesterolemia Clinical Trials in Pittsburgh

Familial hypercholesterolemia is a genetic condition causing very high LDL cholesterol levels from birth, dramatically increasing the risk of early heart disease. It affects about 1 in 250 people. Treatment includes high-intensity statins, PCSK9 inhibitors, and lifestyle modifications.

There are currently 2 familial hypercholesterolemia clinical trials recruiting participants in Pittsburgh, PA. These studies are seeking a combined 229 participants. Research is being sponsored by Novartis Pharmaceuticals, Regeneron Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.

Familial Hypercholesterolemia Clinical Trials in Pittsburgh — FAQ

Are there familial hypercholesterolemia clinical trials in Pittsburgh?

Yes, there are 2 familial hypercholesterolemia clinical trials currently recruiting in Pittsburgh, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Pittsburgh?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Pittsburgh research site will contact you about next steps.

Are clinical trials in Pittsburgh free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Pittsburgh studies also compensate for your time and travel.

What familial hypercholesterolemia treatments are being tested?

The 2 active trials in Pittsburgh are testing new therapies including novel drugs, biologics, and treatment approaches for familial hypercholesterolemia.

Data updated October 16, 2026 from ClinicalTrials.gov